BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7041941)

  • 1. Free serum hydroxyproline and total urinary hydroxyproline for the detection of skeletal metastasis.
    Gasser AB; Depierre D; Mermillod B; Courvoisier B
    Br J Cancer; 1982 Mar; 45(3):477-81. PubMed ID: 7041941
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone alkaline phosphatase isoenzyme and urinary hydroxyproline in healthy subjects, patients with osteolytic metastases, and patients with primary hyperparathyroidism.
    Stĕpán JJ; Mikulecký M; Bek V; Broulík P; Pacovský V
    Neoplasma; 1989; 36(4):495-501. PubMed ID: 2770935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary hydroxyproline, serum alkaline phosphatase, calcium and phosphorus in patients with bone neoplasms.
    Radom S; Zulawski M; Golebiowska D
    Pol Med J; 1972; 11(4):809-14. PubMed ID: 4342776
    [No Abstract]   [Full Text] [Related]  

  • 4. Relevance of hydroxyproline excretion to bone metastasis in breast cancer.
    Gielen F; Dequeker J; Drochmans A; Wildiers J; Merlevede M
    Br J Cancer; 1976 Sep; 34(3):279-85. PubMed ID: 974001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary hydroxyproline excretion in patients with cancer.
    Guzzo CE; Pachas WN; Pinals RS; Krant MJ
    Cancer; 1969 Aug; 24(2):382-7. PubMed ID: 5796782
    [No Abstract]   [Full Text] [Related]  

  • 6. Total urinary and free serum hydroxyproline in metastatic bone disease.
    Gasser AB; Depierre D; Courvoisier B
    Br J Cancer; 1979 Mar; 39(3):280-3. PubMed ID: 465297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of calcitonin and hexestrol on urinary excretion of hydroxyproline in a patient with prostatic cancer and bone metastases.
    Matsushita Y; Hasegawa K; Sugimura R; Otomo S; Morii H
    Endocrinol Jpn; 1974 Apr; 21(2):109-13. PubMed ID: 4408206
    [No Abstract]   [Full Text] [Related]  

  • 8. Total urinary hydroxyproline excretion before and after hypophysectomy in patients with bone metastases from breast carcinoma.
    Ditzel J; Jordal R; Riskaer N
    Acta Endocrinol (Copenh); 1968 Nov; 59(3):353-61. PubMed ID: 5754976
    [No Abstract]   [Full Text] [Related]  

  • 9. [Urinary and serum hydroxyproline in the diagnosis of bone metastases of prostatic cancer].
    Gasser AB; Jeannet C; Depierre D; Courvoisier B
    Schweiz Med Wochenschr; 1981 Feb; 111(8):246-51. PubMed ID: 7233140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyproline excretion in patients with breast cancer and response to treatment.
    Powles TJ; Leese CL; Bondy PK
    Br Med J; 1975 Apr; 2(5964):164-6. PubMed ID: 1125725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian rhythm of total urinary hydroxyproline excretion and 3-H hydroxyproline test.
    Radom S; Zulawski M; Dahlig E
    Clin Chim Acta; 1972 Jun; 39(1):277-8. PubMed ID: 4556834
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hydroxyproline in the diagnosis of bone metastases in breast cancer].
    Gasser AB; Depierre D; Alberto P; Courvoisier B
    Schweiz Med Wochenschr; 1977 Jul; 107(28):984-6. PubMed ID: 897640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of urinary hydroxyproline and bone isoenzyme of alkaline phosphatase in the early detection and follow-up of bone metastasis in breast cancer patients.
    Frenay M; Namer M; Boublil JL; Khater R; Viot M; François E; Milano G
    Bull Cancer; 1988; 75(6):533-9. PubMed ID: 3416085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone collagen and calcium metabolism in normocalcemic and hypercalcemic patients with breast cancer.
    Lee CA; Lloyd HM
    Cancer; 1971 May; 27(5):1099-105. PubMed ID: 5092517
    [No Abstract]   [Full Text] [Related]  

  • 15. [Urine hydroxyproline, serum alkaline phosphatase, calcium and phosphorus in neoplastic diseases].
    Radom S; Zulawski M; Golebiowska D
    Nowotwory; 1971; 21(4):267-73. PubMed ID: 5138713
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinary hydroxyproline and plasma mucoprotein as an indication of the presence of bone metastases.
    Basu TK; Donaldson D; Williams DC
    Oncology; 1974; 30(3):197-203. PubMed ID: 4459734
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary hydroxyproline excretion as a marker of bone metastasis in prostatic cancer.
    Rinsho K; Aoyagi K
    Tohoku J Exp Med; 1982 Aug; 137(4):461-2. PubMed ID: 7123546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CORRELATION OF URINARY HYDROXYPROLINE, SERUM ALKALINE PHOSPHATASE AND SKELETAL CALCIUM TURNOVER.
    KLEIN L; LAFFERTY FW; PEARSON OH; CURTISS PH
    Metabolism; 1964 Mar; 13():272-84. PubMed ID: 14127694
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary hydroxyproline excretion in early and advanced breast cancer-a sequential study.
    Cuschieri A
    Br J Surg; 1973 Oct; 60(10):800-3. PubMed ID: 4748385
    [No Abstract]   [Full Text] [Related]  

  • 20. [Urinary hydroxyproline excretion before and after hypophysectomy in patients with bone metastases from breast cancer].
    Ditzel J; Jordal R; Riskoer N
    Ugeskr Laeger; 1968 Oct; 130(42):1766-71. PubMed ID: 5724711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.